Tim Wright, Editor, Contract Pharma03.09.21
Sharp, part of UDG Healthcare plc, a global provider of contract packaging and clinical supply services, has appointed Ria Rhemrev-Boom as its new lead EU Qualified Person (QP) for market release services.
In her new role, Ria will take responsibility for leading Sharp’s QP release to market services for its customers, ensuring the medicines manufactured, packaged and handled throughout the supply chain comply with EU GMP rules and all applicable regulatory standards.
Ria has a PhD in Medical Science from the University of Groningen and has worked across a number of key roles in the pharma and biotechnology industry in a career spanning over 35 years, including R&D manager, Lab Director and CEO for a variety of service organizations. She has extensive experience in delivering QP services and implementing quality management systems (QMS).
“Ria’s appointment is a key part of Sharp’s strategy of ensuring we offer a full suite of services for our customers,” said Robert O’Beirn, managing director, Sharp Europe. “This will be particularly important to biotech manufacturers and virtual businesses as they often require support in the EU in relation to the release of their products onto the market.
“She will be instrumental in helping to streamline the journey of our customers’ products to market in the EU and will further enhance the strong quality culture in the Sharp EU organisation, led by Chris Bruyninckx, QA/RA Manager of Sharp Europe.”
Complemented by Sharp’s new cloud-based QMS, QualityOne, and the implementation of an Electronic Batch Record infrastructure, the addition of QP market release services means the company can now offer enhanced packaging and release services. These new capabilties will help pharmaceutical companies around the globe to bring their products to the market faster and more efficiently.
In her new role, Ria will take responsibility for leading Sharp’s QP release to market services for its customers, ensuring the medicines manufactured, packaged and handled throughout the supply chain comply with EU GMP rules and all applicable regulatory standards.
Ria has a PhD in Medical Science from the University of Groningen and has worked across a number of key roles in the pharma and biotechnology industry in a career spanning over 35 years, including R&D manager, Lab Director and CEO for a variety of service organizations. She has extensive experience in delivering QP services and implementing quality management systems (QMS).
“Ria’s appointment is a key part of Sharp’s strategy of ensuring we offer a full suite of services for our customers,” said Robert O’Beirn, managing director, Sharp Europe. “This will be particularly important to biotech manufacturers and virtual businesses as they often require support in the EU in relation to the release of their products onto the market.
“She will be instrumental in helping to streamline the journey of our customers’ products to market in the EU and will further enhance the strong quality culture in the Sharp EU organisation, led by Chris Bruyninckx, QA/RA Manager of Sharp Europe.”
Complemented by Sharp’s new cloud-based QMS, QualityOne, and the implementation of an Electronic Batch Record infrastructure, the addition of QP market release services means the company can now offer enhanced packaging and release services. These new capabilties will help pharmaceutical companies around the globe to bring their products to the market faster and more efficiently.
